A 60 -year-old mall p resented with mal ignant fib ro us histiocyt onia of the oropha rynx. The ma ss exte nded into the nasoph arynx and laryux and cause d severe upp er airway obstruction that required etnerge ncy tracheotomy. Teil yea rs earlier, lie had utulergone a right partlal g loss ec tonty and segme ntal mandibulectom y fo r squatnous ce ll carcinoma ofthe right tongu e ba se.foll ow ed by 50 Gy of radiation deli ver ed o ver 33 se ss ions. The tum or was so aggressi ve that change s in its volume lI'ere visually distin gui sliable durin g physical examination ove r a 2week hosp ital stay. Histologic eva luation reve aled 7 mitotic figures per high-powerfield . A ltho ugh rad iati onindn eed malign ant fi brous liistiocyt om a is ra re iil the head and neck, the recent medi cal litera ture indi cates tha t its incidenee is rising . This rise ha s been attributed to the increa sed effectiveness of head and neck cattcer therapy, whi ch results iil prolotigin g patients ' survival and. lience, their risk of sub sequcnt dis ease. Becau se malignant fibrous histi ocytoma is a late co mp lication of radiation therapy, appea ring on e vera ge 10 ye ars fo llo wing treatment, it is impo rtant that phys icians who treat head and neck cance r monitor these pati ents over the long tenn and remaiil alen f or its appea rance, ev eli despite the appa rent ..cure" of their origina l neop lasm.
fibro us histioc ytoma.' Thi s turnor arises most often in the soft tissues of the extremities and retroperitoneum; it has been con sid ered rare in the head and neck. t In 1989 , the cumulative incidenee of sureoma foll owing radiation therap y wa s reported to range from 0.03 to 0.3% .5 However, an ana lys is publi shed in 199 8 rep orted a higher inciden ee of I to 3%.6 Thi s rise in incid en ee is likely attributable to the inereased effe etiveness ofeaneertherapy, whieh prolongs surviva l and increases the risk o f eventua l postr adi ati on ca nce r.' Th erefore, it is import ant that surgeons wh o treat head and neek eane er be eo gniza nt of thi s long-term postradiation complication and to eontinue to follow these patients ind efinitely.
Case report
A 60-year-old man present ed with a I-month history of pr ogressively wo rse ning dy sphonia and dyspnea , wh ieh required an emerge ney traeh eotomy to es tablish an airwa y. Ten years ea rlie r, he had und ergon e a right parti al glosseetomy and seg me nta l mandibuleet om y for squamou s ee lI ca rcino ma of the right tongue base, follo wed by 50 G y of radi ation deli vered over 33 sessions at another institution .
Computed tomography (CT ) of the neek revealed that a bulky tumor extended from the nasopharynx to the level of the true vocal fold s-predominatel y on left side, but erossing the midline. Th e tumor invol ved the right ton gu e base, and it displaeed and fill ed the le ft py riform sinus and va llee ula (figure I).
Flexibl e laryn goseop y rev ealed that the mass oee upied the nasoph aryn x, and direet laryn goseop y und er ge nera l anes thes ia foll owing traeheotom y deteeted a left ton guebase tumor with a di am eter o f at least 5 cm in the supraglottie region. Th e left neek mas s mea sured 3 cm in The patient and his fami1y declined further treatment. During routine daily physical examinations over a 2-week hospital stay, a substantial increase in the volume of the ora1 mass could be seen, which illustrates the aggressive nature and rapid growth of ma1ignant fibrous histiocytoma. The patient died approximately 2 mon ths later.
Discussion
Malignant fibrous histiocytoma is asubtype of sarcoma that originates in fibroblasts; it is the most common radiation-induced sarcoma of the head and neck, and it accounts for approximately 5% of all head and neck A i~t~· .' sarcomas.' Factors associated with a poor prognosis are tumor size larger than 3 cm , high-grade histology, advanced age , and male sex'":
• Tumors larger than 3 cm are associated with a 42 % mortality rate , while the mortality rate for smaller tumors has been reported to be only 18%.6 • The 5-year survival rate is 32% for patients with high-grade histology, compared with 81% for those with low-grade histology." • The mortality rate among patients 01der than 60 years is 72%, compared with 33% for patients aged 20 to 39 years. "
Approximately 30% of all cases of malignant fibrous histiocytoma of the head and neck involve the sinonasal tract; 15 to 20% involve the craniofacial region; 10 to 15% involve the soft tissue of the neck, the major saiivary glands, and the larynx; and 5 to 15% involve the oral cavity.? Wide radical surgical excision is the treatment of choice for malignant fibrou s histiocytoma. When regional lymph nodes are invo lved, neck dissection is warranted. Doxorubic in is the only chemotherapeutic agent known to exhibi t some efficacy again st malignant fibro us histiocytoma . Radiation therapy is not very effective, but it has been used for unresectable tumors and in patients who have positive margin s after surgical resection."
In conclusion , advances in the treatment of head and neck malignancies have led to better survival rates among affec ted patients. Moreover, radiation therapy has been used widely during the past 20 to 30 years for treating lowstage head and neck cancers. Therefore, the rise in the incidenee of radiation-induced malignancies such as malignant fibrous histiocytoma should not be surprising . Physicians who treat head and neck cancers sho uld be cognizant of the occ urrence of radi ation -induced tumor s, and long-term follow-up is advisable so that such tumors can be detected early.
Four criteria must be met before a malignant fibrou s histiocytoma can be diag nosed as a radiation-induced tumor":":
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